3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Radiosurgery
28
Magnetic Resonance Spectroscopy
15
Temozolomide
14
pembrolizumab
13
Bevacizumab
11
Nivolumab
10
Ipilimumab
8
Memantine
7
Specimen Handling
6
Radiotherapy
6
Mental Status and Dementia Tests
6
abemaciclib
5
Blood Specimen Collection
5
Radiation
4
trastuzumab deruxtecan
3
entrectinib
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Biopsy
3
trametinib
2
pertuzumab
2
osimertinib
2
lenvatinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.